These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 23205539)
21. Mechanisms of ultraviolet-induced melasma formation: A review. Yang J; Zeng J; Lu J J Dermatol; 2022 Dec; 49(12):1201-1210. PubMed ID: 35946331 [TBL] [Abstract][Full Text] [Related]
22. Advances in the treatment of melasma: a review of the recent literature. Ball Arefiev KL; Hantash BM Dermatol Surg; 2012 Jul; 38(7 Pt 1):971-84. PubMed ID: 22583339 [TBL] [Abstract][Full Text] [Related]
23. Melasma in a transgender woman. Garcia-Rodriguez L; Spiegel JH Am J Otolaryngol; 2018; 39(6):788-790. PubMed ID: 30104074 [No Abstract] [Full Text] [Related]
24. African ancestry is associated with facial melasma in women: a cross-sectional study. D'Elia MP; Brandão MC; de Andrade Ramos BR; da Silva MG; Miot LD; Dos Santos SE; Miot HA BMC Med Genet; 2017 Feb; 18(1):17. PubMed ID: 28212612 [TBL] [Abstract][Full Text] [Related]
25. Prevalence and awareness of melasma during pregnancy. Moin A; Jabery Z; Fallah N Int J Dermatol; 2006 Mar; 45(3):285-8. PubMed ID: 16533230 [TBL] [Abstract][Full Text] [Related]
26. Melasma: a review. Victor FC; Gelber J; Rao B J Cutan Med Surg; 2004; 8(2):97-102. PubMed ID: 15685388 [TBL] [Abstract][Full Text] [Related]
27. Melasma in men: a clinical, aetiological and histological study. Sarkar R; Puri P; Jain RK; Singh A; Desai A J Eur Acad Dermatol Venereol; 2010 Jul; 24(7):768-72. PubMed ID: 20015053 [TBL] [Abstract][Full Text] [Related]
28. [The role of sex hormones in the pathogenesis of melasma]. Goandal NF; Rungby J; Karmisholt KE Ugeskr Laeger; 2022 Feb; 184(6):. PubMed ID: 35179119 [TBL] [Abstract][Full Text] [Related]
30. Melasma: a comprehensive update: part I. Sheth VM; Pandya AG J Am Acad Dermatol; 2011 Oct; 65(4):689-697. PubMed ID: 21920241 [TBL] [Abstract][Full Text] [Related]
31. The pathogenesis of melasma and implications for treatment. Artzi O; Horovitz T; Bar-Ilan E; Shehadeh W; Koren A; Zusmanovitch L; Mehrabi JN; Salameh F; Isman Nelkenbaum G; Zur E; Sprecher E; Mashiah J J Cosmet Dermatol; 2021 Nov; 20(11):3432-3445. PubMed ID: 34411403 [TBL] [Abstract][Full Text] [Related]
33. Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis. Jang YH; Lee JY; Kang HY; Lee ES; Kim YC J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1312-6. PubMed ID: 20337826 [TBL] [Abstract][Full Text] [Related]
37. Morphologic changes and the expression of alpha-melanocyte stimulating hormone and melanocortin-1 receptor in melasma lesions: a comparative study. Miot LD; Miot HA; Polettini J; Silva MG; Marques ME Am J Dermatopathol; 2010 Oct; 32(7):676-82. PubMed ID: 20534990 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of 694-nm Q-switched ruby fractional laser treatment of melasma in female Korean patients. Jang WS; Lee CK; Kim BJ; Kim MN Dermatol Surg; 2011 Aug; 37(8):1133-40. PubMed ID: 21585597 [TBL] [Abstract][Full Text] [Related]